nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
CAP superfamily proteins in human: a new target for cancer therapy
|
Zhou, Shenao |
|
|
41 |
12 |
|
artikel |
2 |
Complete decongestive therapy phase 1: an expert consensus document
|
DiCecco, Shelley |
|
|
41 |
12 |
|
artikel |
3 |
Impaired cyclin D3 protein degradation contributes to trastuzumab resistance in HER2 positive breast cancer
|
Wang, Zhuo |
|
|
41 |
12 |
|
artikel |
4 |
Intratumoral microbiota: an emerging force in diagnosing and treating hepatocellular carcinoma
|
Liu, Huanxiang |
|
|
41 |
12 |
|
artikel |
5 |
Letter to the editor on “Targeted gene therapy for cancer: the impact of microRNA multipotentiality”
|
Ameya, K. P. |
|
|
41 |
12 |
|
artikel |
6 |
lncRNAs’p potential roles in the pathogenesis of cancer via interacting with signaling pathways; special focus on lncRNA-mediated signaling dysregulation in lung cancer
|
Shelash, Sulieman Ibrahim |
|
|
41 |
12 |
|
artikel |
7 |
Mitoepigenetics pathways and natural compounds: a dual approach to combatting hepatocellular carcinoma
|
Hatawsh, Abdulrahman |
|
|
41 |
12 |
|
artikel |
8 |
ML385 promotes ferroptosis and radiotherapy sensitivity by inhibiting the NRF2-SLC7A11 pathway in esophageal squamous cell carcinoma
|
Yan, Ling |
|
|
41 |
12 |
|
artikel |
9 |
Self-assembled nanoparticles of alginate and paclitaxel-triphenylphosphonium for mitochondrial apoptosis targeting
|
Esfandyari-Manesh, Mehdi |
|
|
41 |
12 |
|
artikel |
10 |
Targeting the undruggable in glioblastoma using nano-based intracellular drug delivery
|
Shirvalilou, Sakine |
|
|
41 |
12 |
|
artikel |
11 |
The role of molecular biomarkers in recurrent glioblastoma trials: an assessment of the current trial landscape of genome-driven oncology
|
Ameya, K. P. |
|
|
41 |
12 |
|
artikel |
12 |
Understanding the chemistry & pharmacology of antibody–drug conjugates in triple-negative breast cancer with special reference to exatecan derivatives
|
Sawant, Sanjana |
|
|
41 |
12 |
|
artikel |